Genitourinary Cancer Archives | VJOncology

The GU Cancer Channel on VJOncology is supported by Exelixis. The GU Cancer Channel is also supported by an educational grant from Pfizer Inc. and Merck KGaA. These supporters have no influence over the production of the content.

View overview page

Innovation and care in the next 12 months for prostate cancer

Eva Compérat • 7 Mar 2023

Results from dataset analysis of CDH1-mutated urothelial carcinoma patients

Andrea Necchi • 18 Feb 2023

Genomic landscape and tumor neoantigen burden for penile squamous cell cancer

Andrea Necchi • 18 Feb 2023

Novel approaches for risk stratification of newly diagnosed localized prostate cancer

Phuoc T. Tran • 23 Feb 2023

Improving the prognosis of prostate cancer

Massimo Lazzeri • 16 Feb 2023

Genomic features of mediastinal germ cell tumors

Lucia Nappi • 16 Feb 2023

How far away are we from implementing liquid biopsy approaches in GU cancers?

Lucia Nappi • 16 Feb 2023

UNITE: biomarkers of response to enfortumab vedotin in patients with advanced urothelial carcinoma

Vadim Koshkin • 23 Feb 2023

Next steps following the FORMULA-509 trial: PROSTATE-IQ

Paul L. Nguyen • 23 Feb 2023

How real-time molecular imaging can improve the management of prostate cancer

Anthony Victor D'Amico • 16 Feb 2023

How can we improve outcomes for patients with kidney cancer who receive immunotherapy?

Mark Wayne Ball • 18 Feb 2023

Treatment landscape of penile cancer

Talal El Zarif • 16 Feb 2023

Highlights in penile cancer at ASCO GU 2023

Maarten Albersen • 17 Feb 2023

Unmet needs for patients with advanced RCC

Tian Zhang • 17 Feb 2023

Unmet needs for penile cancer

Maarten Albersen • 17 Feb 2023

What’s on the horizon for adjuvant therapies for RCC?

Matthew R. Zibelman • 16 Feb 2023

1
2
3
4
5
…
8
Next